Remedial Effect of Intravenous Cyclophosphamide in Corticosteroid-Refractory Patients in the Acute Phase of Neuromyelitis Optica Spectrum Disorder-Related Optic Neuritis

Background: To investigate the remedial efficacy and safety of intravenous cyclophosphamide (CP) in the acute phase in patients with neuromyelitis optica spectrum disorder-related optic neuritis (NMOSD-ON) who are refractory to intravenous methylprednisolone (MP) treatment. Design: This study was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ling, Liu, Kaiqun, Tan, Xiao, Zhou, Lin, Zhang, Yuxin, Liu, Xiaoning, Fu, Yue, Qiu, Wei, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874161/
https://www.ncbi.nlm.nih.gov/pubmed/33584513
http://dx.doi.org/10.3389/fneur.2020.612097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874161/
https://www.ncbi.nlm.nih.gov/pubmed/33584513
http://dx.doi.org/10.3389/fneur.2020.612097

Ejemplares similares